Featured Research

from universities, journals, and other organizations

Low-cost drug may lessen blood loss in hip, knee surgery

Date:
August 21, 2014
Source:
Mount Sinai Medical Center
Summary:
Treatment with an inexpensive, decades-old clotting drug reduces the need for blood transfusions, research shows. While commonly used in patients with bleeding disorders or heavy menstrual bleeding, the clotting drug tranexamic acid is now increasingly used to prevent excessive blood loss during hip and knee replacement surgery, a million of which are now performed each year in the United States.

Treatment with an inexpensive, decades-old clotting drug reduces the need for blood transfusions during and after hip and knee replacement surgeries without increasing the risk of complications, according to a study by researchers at Icahn School of Medicine at Mount Sinai and Hospital for Special Surgery published online in the British Medical Journal.

While commonly used in patients with bleeding disorders or heavy menstrual bleeding, the clotting drug tranexamic acid is now increasingly used to prevent excessive blood loss during hip and knee replacement surgery, a million of which are now performed each year in the United States. While there are benefits to this drug, there are also safety concerns as it prevents enzymes in the body from breaking down blood clots that could potentially cause complications such as thrombosis.

"Our study, an analysis of past data, found that the use of tranexamic acid in patients undergoing hip or knee replacement surgery was associated with an up to 70 percent decrease in the need for a blood transfusion, and without an increased risk of complications related to clotting." said Jashvant Poeran, MD, PhD, Assistant Professor, Institute of Healthcare Delivery Science, Department of Population Science, Icahn School of Medicine at Mount Sinai, and lead author of the newly published study. "An increasing number of patients will require these surgeries as America ages, and maintaining their safety is very important."

Using data from a national database, the researchers analyzed 872,416 total hip or knee replacement procedures at 510 US hospitals between 2006 and 2012. After adjusting for factors such as patient age, sex, hospital size and location, type of procedure and anesthesia used, patients given tranexamic acid (1000 mg, 2000 mg, or 3000 mg) on the day of surgery were compared with patients not given the drug.

The research team also found use of tranexamic acid to be associated with lower rates of admission to an intensive care unit (ICU), lower length of hospital stay, and lower costs of hospital stay. A dose of 2000 mg of tranexamic acid appeared to have the best effectiveness and safety profile.

"While there are some limitations to our study, the results appear to support the current practice of increasing use of this drug in hip and knee surgery," said Dr. Poeran. "Identifying patients most likely to benefit -- that is those at increased risk of bleeding and for requiring blood transfusions -- is crucial. Additional studies are needed to confirm this benefit, including those that focus on optimal dosing."


Story Source:

The above story is based on materials provided by Mount Sinai Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Poeran, R. Rasul, S. Suzuki, T. Danninger, M. Mazumdar, M. Opperer, F. Boettner, S. G. Memtsoudis. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 2014; 349 (aug12 8): g4829 DOI: 10.1136/bmj.g4829

Cite This Page:

Mount Sinai Medical Center. "Low-cost drug may lessen blood loss in hip, knee surgery." ScienceDaily. ScienceDaily, 21 August 2014. <www.sciencedaily.com/releases/2014/08/140821153516.htm>.
Mount Sinai Medical Center. (2014, August 21). Low-cost drug may lessen blood loss in hip, knee surgery. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2014/08/140821153516.htm
Mount Sinai Medical Center. "Low-cost drug may lessen blood loss in hip, knee surgery." ScienceDaily. www.sciencedaily.com/releases/2014/08/140821153516.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins